The nurse should instruct the client that amitriptyline causes the anticholinergic effect of urinary
retention.
2. Fentanyl patches
Constipation is an adverse effect of opioid use and stool softeners can decrease the severity of this
adverse effect.
3. Decongestants
can constrict blood vessels; causing Hypertension
4. tamoxifen (side effects)
menstrual irregularities, hot flashes, bruising
5. opioid (side effect and tx)
constipation; give stool softener
6. cefazolin allergic reaction (tx)
parenteral epinephrine (induce vasoconstriction and bronchodilation)
7. metoprolol use post MI (what to monitor)
bilateral crackles in the lungs (sign of heart failure)
8. over the counter drug to AVOID when taking Lithium
NSAIDs (increases lithium levels)
9. therapeutic value for INR 2 to 3
10. sulfa allergy (cross sensitivity to which drugs)
thiazide diuretics
11. enalapril use for Heart failure (what to monitor)
hyperkalemia
12. methotrexate (what to monitor/report)
fever, sore throat, sores in mouth, infection
13. pilocarpine eye drops
need to be taken for the rest of your life; tx for Glaucoma
14. when should Oxytocin IV post-term pregnancy be discontinued? (contractions)
uterine contractions last 60 secs or longer
15. when should Oxytocin IV post-term pregnancy be discontinued? (resting uterine pressure)
greater than 15-20mmHg
16. when should Oxytocin IV post-term pregnancy be discontinued? (uterine contraction frequency)
more than every 2-3 mins
17. trimethoprim/sulfamethoxazole (adverse effect to report)
vesicular, crusty rash (Steven Johnson syndrome)
, 18. trimethoprim/sulfamethoxazole (teaching)
drink 8-10 glasses of water daily to prevent renal damage from CRYSTALLURIA
19. donepezil (adverse effects)
dyspnea (priority), dizziness, diarrhea, dyspepsia
20. spironolactone (adverse effect)
lethargy r/t HYPERKALEMIA
21. potassium-sparing diuretic (drug)
spironolactone
22. digoxin toxicity (sign to monitor and report)
yellow-tinged vision
23. TSH therapeutic level 0.5-2 microunits
T3 therapeutic level 0.0001-0.0002 mcg
T4 therapeutic level 4.5-11.2 mcg
24. methotrexate toxicity (sign to monitor and report)
sores in mouth (stomatitis)
25. oxybutynin (adverse effects)
dry mouth
blurred vision
photophobia
constipation
26. TACHYCARDIA (anticholinergic effects)
27. urinary incontinence ( tx drug) oxybutynin (anticholinergic)
28. Isotretinoin (required test before use/obtaining a refill)
pregnancy test (teratogenic)
29. severe nodulocystic acne vulgaris (tx drug)
Isotretinoin
30. Dopamine IV (therapeutic use during cardiogenic shock)
increased blood pressure (catecholamine effect)
increased HR
increased renal output/voiding
31. candidiasis (tx drug)
Fluconazole (antifungal)
32. Sodium Polystyrene Sulfate (therapeutic use)
decrease serum potassium to prevent cardiac dysrhythmias r/t HYPERKALEMIA